Tuttle Destroys NASEM’s Lyme Disease Report

May 16, 2025

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough!

Carl Tuttle
Hudson, NH, United States
May 15, 2025

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough so now we have yet another distraction avoiding the elephant in the room (chronic Lyme) called Lyme IACI; “Lyme Infection-Associated Chronic Illness.”

That should add another decade to the denial of chronic Lyme allowing the pharmaceutical industrial complex to roll out its Lyme vaccine and payouts in the form of patent royalties to all those responsible for this crime against humanity. It was that rush to create a vaccine early in the discovery phase of the epidemic that led to the deliberate mishandling of the disease. All the eggs were put into the vaccine basket before a cure was researched and uncovered. We have been dealing with an antibiotic resistant/tolerant superbug but the vaccine money grab was far too lucrative to pass up. Covid proved to us all that our Public Health Officials will do or say anything for the sake of a vaccine; “Safe and Effective“??????

Please take a moment to read the following inquiry sent to Marcia McNutt, President of the National Academy of Sciences regarding a recent publication referencing the latest acronym “Lyme IACI.”

Image of McNutt was found here: https://www.nasonline.org/directory-entry/marcia-mcnutt-6apamq/

Inquiry to Marcia McNutt:

———- Original Message ———-

From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/14/2025 8:50 AM EDT
Subject: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness

The National Academies Press

Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness (“Lyme IACI”)
https://nap.nationalacademies.org/read/28578/chapter/1

Marcia McNutt

President of the National Academy of Sciences and Chair of the National Research Council

“Most of my current activity centers around meta science – how to shape the culture and conduct of science to build trust, excellence, inclusiveness, and integrity.” – Marcia McNutt

Dear Marcia McNutt,

After reading through your Biosketch you seem to have the capability to detect scientific fraud. Would suppressing evidence of antibiotic resistance (for the sake of a vaccine) constitute a crime? Please take a moment to read the following inquiry addressed to Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention. If the scientific references/evidence I provide were not suppressed the focus would have been on finding effective antimicrobials to treat this antibiotic resistant/tolerant superbug.

Question: Has the National Academy of Sciences under your direction just had the wool pulled over their eyes?

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Victor J. Dzau President, National Academy of Medicine

William Kearney Executive Director of the Office of News and Public Information

David May Director, National Academies Press

Alphonse MacDonald Publisher, National Academies Press

Inquiry to: Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention

———- Original Message ———-

From: CARL TUTTLE <runagain@comcast.net>
To: “grace.marx@cuanschutz.edu” <grace.marx@cuanschutz.edu>, “gmarx@cdc.gov” <gmarx@cdc.gov>
Cc: “katrina.rouse@usdoj.gov” <katrina.rouse@usdoj.gov>, “jonathan.kanter@usdoj.gov” <jonathan.kanter@usdoj.gov>
Date: 10/25/2024 9:11 AM EDT

Subject: Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects

Tick-Borne Diseases and Associated Illnesses, Community Engagement Series: Mental Health and Neurological Effects
https://www.hhs.gov/oidp/initiatives/tick-borne-diseases-associated-illnesses-national-community-engagement-initiative/index.html

3:00 pm – 3:20 pm   A Clinician Toolkit: Improving Care for Patients with Prolonged Symptoms and Concerns about Lyme Disease By Grace E. Marx, MD Medical Epidemiologist, Centers for Disease Control and Prevention

Dear Dr. Marx,

I listened to your presentation yesterday with great interest and I must congratulate you for your outstanding performance in suppressing all evidence of persistent infection; chronic Lyme disease.

We have studies proving persistent infection after antibiotic treatment for mice, dogs, ponies,  monkeys, cows, iris biopsy, and ligamentous tissue but if you perform a simple Google search for the following statement, “There is no convincing scientific evidence that chronic Lyme exists” you will find the top search results are connected to “elements of academic medicine” involved in the denial of the late stage Lyme epidemic.

In 1991 the Lyme disease organism, Borrelia burgdorferi, was grown from the cerebrospinal fluid of Lyme patient Vicki Logan at the Centers for Disease Control in Fort Collins, Colorado despite prior treatment with intravenous antibiotics. The patient died when the insurer refused additional IV antibiotics. Here is a copy of Logan’s CDC positive culture report for your review.

(Vicky Logan’s Chronic Lyme Autopsy results Page #1, 2, 3, 4, 5, 6, 7)

There are 700 peer-reviewed publications referencing persistent infection and in a 2018 study all patients were culture positive even after multiple years on antibiotics so there was no relief from current antimicrobials. Some of these patients had taken as many as eleven different types of antibiotics.

Thirty-four years ago Dr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits.

Here is Dr. Steere’s 1990 publication summary for your review:

The New England Journal of Medicine 

Published November 22, 1990

Chronic neurologic manifestations of Lyme disease
https://www.nejm.org/doi/full/10.1056/NEJM199011223232102

The chart below summarizes Lyme research funded by the NIH and only 2.5% has been allocated for treatment:

[Click on the link above to view the chart]

For the record there are many infections requiring long-term antibiotics so why Klempner stopped his NIH funded antibiotic treatment trials for Lyme after 90 days makes absolutely no sense whatsoever:

From the following publication:

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease
https://www.dovepress.com/benefit-of-intravenous-antibiotic-therapy-in-patients-referred-for-tre-peer-reviewed-fulltext-article-IJGM

Infections requiring long-term antibiotics:

[Download the article and View Table 4 as there are nine infections listed] 

Lyme misdiagnosed/undiagnosed for months, years or decades is far more incapacitating than “acute” Lyme and 2-4 weeks of antibiotics does not scratch the surface of this well-established/immune suppressive infection. These are the patients who need help the most but have been excluded in research for decades. There are countless stories of patients seroconverting after the initial few doses of Doxycycline and now that a toxin has been identified that puts Lyme disease in an altogether different category of infection:

Toxins 

Published: 21 May 2024

Borrelia burgdorferi 0755, a Novel Cytotoxin with Unknown Function in Lyme Disease
https://www.mdpi.com/2072-6651/16/6/233

So it would appear that one way to get a medical association (AMA) to go along with the suppression of evidence is to throw them a boatload of money… five million taxpayer dollars to be exact for a so-called IDSA biased “Clinician Toolkit”  (CDC grant number  NU50CK000597)

This controlling of the narrative has caused unimaginable pain and suffering all across America as insurance companies refuse to pay for long-term treatment, personal bankruptcies from out-of-pocket expenses to treat chronic infection, suicides from despair all while Valneva Received FDA Fast Track Designation for its Lyme Disease Vaccine.

Chronic Lyme must be recognized and finally addressed with 100% attention to effective antimicrobials for all stages of disease.

Question:

Is collusion to control the narrative through suppression of the truth, facts and scientific references a criminal offense?

Carl Tuttle
Hudson, NH

Cc: Assistant Attorney General Jonathan Kanter, Attorney Katrina Rouse

Attorneys for the United States Antitrust Division

Assistant Attorney General Jonathan Kanter Announces Task Force on Health Care Monopolies and Collusion
https://www.justice.gov/opa/pr/assistant-attorney-general-jonathan-kanter-announces-task-force-health-care-monopolies-and

“Every year, Americans spend trillions of dollars on health care, money that is increasingly being gobbled up by a small number of payers, providers and dominant intermediaries that have consolidated their way to power in communities across the country,” said Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division. “Led by Katrina Rouse, the task force will identify and root out monopolies and collusive practices that increase costs, decrease quality and create single points of failure in the health care industry.”

2nd email sent to Marcia McNutt:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>
Cc: “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/15/2025 9:14 AM EDT
Subject: Re: The National Academies Press; Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illness

Dear Marcia McNutt,

Please see the inquiry below addressed to Dr. Raymond Dattwyler …..

Dr. Raymond Dattwyler owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral. Raymond Dattwyler, Benjamin Luft, et al have some interesting comments in their application for a Lyme related patent… 

Dattwyler et al. United States Patent 7,605,248 October 20, 2009
https://www.dropbox.com/scl/fi/1yxcrwjfhhw4q47999dug/Raymond-Dattwyler-Grant-2R01AI37256-05A1-from-the-National-Institute-of-Allergy-and-Infectious-Diseases..docx

“Currently, Lyme Disease is treated with a range of antibiotics, e.g., tetracyclines, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful. One of the factors contributing to delayed treatment is the lack of effective diagnostic tools.”

2022 Inquiry to Dr. Raymond Dattwyler: 

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>To: Raymond_Dattwyler@nymc.eduCc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.eduDate: 01/06/2023 2:46 PM EST
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease

npj Vaccines Jan 2022

The year that shaped the outcome of the OspA vaccine for human Lyme disease
https://www.nature.com/articles/s41541-022-00429-5
Raymond J. Dattwyler & Maria Gomes-Solecki

Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author

Dear Dr. Dattwyler,

I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.

For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis: 

European Neurology 1995

Seronegative Chronic Relapsing Neuroborreliosis
https://www.karger.com/Article/Abstract/117104
Lawrence C., Lipton R.B., Lowy F.D., Coyle P.K.d

Abstract

We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen. 

In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 References)
https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

So that brings me to the reason for this email…

Question:

Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?

A response to this inquiry is requested.

Carl Tuttle
Hudson, NH

Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor

Letter to the Editor of the BMJ published June 2020
https://www.bmj.com/content/369/bmj.m1041/rr-1

_______________

**Comment**

Once again, kudos and a big ‘thank you’ go out to Lyme advocate Carl Tuttle for being a junk yard dog that refuses to let go of the jugular vein.

Tuttle has been tireless in writing letters and exposing Oz behind the Lyme curtain: repeated denial and cover-up of chronic, relapsing Lyme disease.

I posted the ‘new treatments for Lyme Infection-Associated Chronic Illnesses’ here:   https://madisonarealymesupportgroup.com/2025/05/09/charting-a-path-towards-new-treatments-for-chronic-lyme-disease/

I had a sinking feeling then that this would amount to nothing but further entrenchment in the old, antiquated and unscientific Lyme narrative.  It appears I was correct.  I included the old 2014 interview with Willy Burgdorfer, which I repost here, where he states research must be started over at square one because the same people have been doing the research and coming up with the same results – nothing!

http://  Approx. 5 Min

Willy Burgdorfer 2014

“Money goes to people that have for the past 30 years produced the same thing.  Nothing.” ~  Willy Burgdorfer

Well, it’s now been a total of more than 40 years and the same thing is being produced, which is nothing.

For more:

Category:

Activism, Lyme, research

Comments Off on Tuttle Destroys NASEM’s Lyme Disease Report